-
A286579-100mgA 350619 hydrochloride.
-
A286579-10mgA 350619 hydrochloride.
-
A286579-25mgA 350619 hydrochloride.
-
A286579-50mgA 350619 hydrochloride.
-
A286831-10mgA 419259 trihydrochloride.
-
A286831-25mgA 419259 trihydrochloride.
-
A286831-50mgA 419259 trihydrochloride.
-
A286831-5mgA 419259 trihydrochloride.
-
A288912-100mgApplicationA-484954 has been used a selective and potent inhibitor to inhibit eEF2K (eukaryotic elongation factor 2 kinase), in order to check the enhancement of synaptic transmission in the stratum radiatum of the hippocampal CA1 region. It has
-
A288912-10mgApplicationA-484954 has been used a selective and potent inhibitor to inhibit eEF2K (eukaryotic elongation factor 2 kinase), in order to check the enhancement of synaptic transmission in the stratum radiatum of the hippocampal CA1 region. It has
-
A288912-25mgApplicationA-484954 has been used a selective and potent inhibitor to inhibit eEF2K (eukaryotic elongation factor 2 kinase), in order to check the enhancement of synaptic transmission in the stratum radiatum of the hippocampal CA1 region. It has
-
A288912-50mgApplicationA-484954 has been used a selective and potent inhibitor to inhibit eEF2K (eukaryotic elongation factor 2 kinase), in order to check the enhancement of synaptic transmission in the stratum radiatum of the hippocampal CA1 region. It has